Descriptor English: | Farber Lipogranulomatosis | ||||
Descriptor Spanish: |
Lipogranulomatosis de Farber
| ||||
Descriptor Portuguese: | Lipogranulomatose de Farber | ||||
Descriptor French: | Lipogranulomatose de Farber | ||||
Entry term(s): |
Acid Ceramidase Deficiencies Acid Ceramidase Deficiency Ceramidase Deficiencies Ceramidase Deficiency Ceramidase Deficiency, Acid Deficiencies, Ceramidase Deficiencies, N-Laurylsphingosine Deacylase Deficiency, Acid Ceramidase Deficiency, Ceramidase Deficiency, N-Laurylsphingosine Deacylase Disease, Farber's Diseases, Farber's Farber Disease Farber's Disease Farber's Diseases Farbers Disease Lipogranulomatosis, Farber N Laurylsphingosine Deacylase Deficiency N-Laurylsphingosine Deacylase Deficiencies N-Laurylsphingosine Deacylase Deficiency |
||||
Tree number(s): |
C10.228.140.163.100.435.825.250 C16.320.565.189.435.825.250 C16.320.565.398.641.803.325 C16.320.565.595.554.825.250 C18.452.132.100.435.825.250 C18.452.584.563.641.803.325 C18.452.648.189.435.825.250 C18.452.648.398.641.803.325 C18.452.648.595.554.825.250 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D055577 | ||||
Scope note: | A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of CERAMIDES in various tissues due to an inherited deficiency of ACID CERAMIDASE. |
||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
Previous Indexing: |
Lipid Metabolism (1952-1976) Lipid Metabolism, Inborn Errors (1987-2008) Lipidoses (1976-2008) Sphingolipidoses (1992-2008) |
||||
Public MeSH Note: | 2009 |
||||
History Note: | 2009 |
||||
DeCS ID: | 53092 | ||||
Unique ID: | D055577 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2009/01/01 | ||||
Date of Entry: | 2008/07/08 | ||||
Revision Date: | 2013/07/08 |
|
Farber Lipogranulomatosis
- Preferred
Concept UI |
M0518626 |
Scope note | A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of CERAMIDES in various tissues due to an inherited deficiency of ACID CERAMIDASE. |
Preferred term | Farber Lipogranulomatosis |
Entry term(s) |
Acid Ceramidase Deficiencies Acid Ceramidase Deficiency Ceramidase Deficiencies Ceramidase Deficiency Ceramidase Deficiency, Acid Deficiencies, Ceramidase Deficiencies, N-Laurylsphingosine Deacylase Deficiency, Acid Ceramidase Deficiency, Ceramidase Deficiency, N-Laurylsphingosine Deacylase Disease, Farber's Diseases, Farber's Farber Disease Farber's Disease Farber's Diseases Farbers Disease Lipogranulomatosis, Farber N Laurylsphingosine Deacylase Deficiency N-Laurylsphingosine Deacylase Deficiencies N-Laurylsphingosine Deacylase Deficiency |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey